Ignite Creation Date:
2024-05-05 @ 10:25 PM
Last Modification Date:
2024-10-26 @ 10:18 AM
Study NCT ID:
NCT01105325
Status:
TERMINATED
Last Update Posted:
2010-10-04
First Post:
2010-03-25
Brief Title:
Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care CIC - Electronic Measurement of Compliance
Status:
TERMINATED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
due to poor patient recruitment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SCAVANCE
Brief Summary:
To study compliance with secondary prevention during the first months following discharge from the cardiac intensive care unit CIC of patients experiencing a first episode of acute coronary syndrome quantitative compliance over 3 months with the two principal treatments of the prescription a statin - rosuvastatin Crestor and a platelet aggregation inhibitor - clopidogrel Plavix using an electronic measure system intelligent blister pack
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None